Hannah Joseph Hospital IPO

Hannah Joseph Hospital IPO is an issue of ₹42 cr book-building issue of fresh shares. The price band of this IPO is set at ₹67 to ₹70 per share, with the lot size for an application being 1,500. The minimum amount of investment required by an individual investor is ₹2,10,000 (3,000 shares). Hannah Joseph Hospital IPO will open for subscription from January 22, 2026, to January 27, 2026, on the BSE SME platform with a tentative listing date fixed as January 30, 2026.

Company Background

Hannah Joseph Hospital Ltd. was incorporated in 2011 as a premier multi-specialty healthcare provider, a Madurai, Tamil Nadu-based company. It operates from a state-of-the-art 2-acre campus, and the 150-bed facility is renowned for its specialized focus on Neurosciences, Cardiac Sciences, Psychiatry, and Trauma care. Hannah Joseph Hospital combines advanced technology—such as central air-conditioning and modular operating theatres—with a patient-centered approach to deliver high-quality, affordable medical services. Supported by a dedicated team of 364 employees, the institution is a regional leader in complex brain, spine, and cardiac interventions.

Operations and Product Range

Facility and Production

The hospital operates a high-tech 150-bed multi-specialty facility on a sprawling 2-acre campus in Madurai. It is one of Asia’s first centers to implement DTI Fibertracking 3.0 for brain tumor precision. Production-level healthcare is supported by modular operating theatres, advanced neuro-intensive care units, and a 24/7 trauma response system capable of handling complex neurological and cardiac emergencies simultaneously.

Brands and Market Presence

Hannah Joseph Hospital Ltd. has established a dominant brand presence in South India as a "Center of Excellence" for Neurosciences and Trauma. It holds prestigious NABH accreditation and NABL certification, signaling quality standards that attract patients across Tamil Nadu. Its market reputation is built on high-end specialized care, positioning it as a preferred referral point for affordable yet elite neuro-psychiatry and cardiac services.

Revenue Channels

When we look at the reports and IPO filings for Hannah Joseph Hospital Ltd., we can see the main ways that Hannah Joseph Hospital Ltd. makes money.

• • The primary revenue source is In-Patient (IP) services, like fees for high-end surgeries and so on.
• • Revenue from medical imaging and tests, including MRI, CT scans, and pathology.
• • Consultancy fees from the individuals who come for advice, not for treatment.
• • Income generation from sales of medicines, surgical consumables, and implants
• • Income generation from the 24/7 emergency & Trauma Care

With the IPO proceeds, the hospital plans to establish a dedicated Radiation Oncology Centre, which will add a significant new revenue stream from cancer treatments and radiotherapy.

Management and Shareholding

Promoters and Shareholding

The promoters of the hospital are Dr. Mosesjoseph Arunkumar and Dr. Fenn Kavitha Fenn Arunkumar. Before the IPO, the promoters held a dominant 90.80% stake in the company (cumulatively 1.55 cr shares). The shareholding structure is designed to maintain promoter control while diluting a portion to the public to fund expansion and clear long-term debt, which stood at ₹28.35 cr in late 2025.

Board Members

The board members of Hanna Joseph Hospital are full of medical expertise and independent governance. Key members include Dr. Moses Joseph Arunkumar (Chairman & Managing Director) and Dr. Fenn Kavitha Fenn Arunkumar (Whole Time Director). They are supported by a strong group of Independent Directors, including Mr. C.N. Srinivasan and Mr. Ranganathan Mukundan, who oversee the Audit and Stakeholders Relationship Committees to ensure transparent corporate governance and regulatory compliance.